The combination of toripalimab, nimotuzumab, and chemotherapy showed “promising antitumor activity with acceptable toxicity,” researchers wrote.

In a phase 3, randomized trial, we enrolled patients with local or regional cutaneous squamous-cell carcinoma, after surgical resection and postoperative radiotherapy, at high risk for recurrence ...

Squamous Cell Carcinoma Treatment. Skin Cancer Foundation. January 2022. Squamous Cell Carcinoma of the Skin: Diagnosis and Treatment. Mayo Clinic. May 13, 2021. Treatment for Squamous Cell Carcinoma.

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

Cutaneous squamous cell carcinoma (cSCC) is one of the most prevalent cancers worldwide, and while most patients are cured, systemic therapy for patients with advanced cSCC is palliative. 1,2 ...

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.

A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.

Medically reviewed by Katlein Franca, MD Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations ...

A healthy 60-year-old man presented with a recurrent lesion on his left third finger after surgical treatment 7 years previously (Figure 1). A biopsy reveals squamous cell carcinoma (SCC) in situ ...

And guys would benefit from paying attention to their skin cancer risk. “The truth is that, in aggregate, men just don’t take ...